You searched for "outcome"

2408 results found

Eye Capacity: clinical need should drive ophthalmic service provision

Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...

Designing ophthalmology services Part 2: How do we address the queues for a clinic?

The first of this three-part series showed how systems engineering can be used to correctly diagnose and address the causes of delays in a clinic. This second article describes how to design a more productive system that meets the new...

Broadening of treatment options for potentially blinding retinal conditions

Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...

Novel retinal pigment metric tackles bias in AI models

Researchers have developed an innovative metric for objectively classifying pigmentation in a retinal image, rather than using subjective social constructs like ethnicity or other demographic variables, as is currently the case when building health datasets. Called the Retinal Pigment Score...

Treatment of anisometropia and strabismus amblyopia with syntonic phototherapy

Syntonic phototherapy is a non-invasive light therapy treatment using specific light colours, frequency and wavelength to improve body regulatory centres in the brain. It is proposed that red light increases cell membrane capacitance buildup of electrical charge before discharge that...

Opening the AI ‘black box’ for glaucoma

Artificial intelligence (AI) models show great promise for glaucoma detection using retinal images, but their ‘black box’ nature is a major barrier to clinical adoption. Clinicians are often hesitant to trust a diagnosis without understanding its reasoning. This paper provides...

Corporate M&A pace gathers momentum

Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...

Welcome to David Lockington - Co-Editor

Eye News is delighted to introduce David Lockington as our new co-editor. Hear from David as he talks about his excitement for the role, and pays tribute to his predecessor Tariq Aslam.

UK CSF Disorders Annual Meeting 2023: The pressure of headache

Hosts: Professor Susan Mollan and Professor Alex Sinclair The annual meeting this year will focus on headaches in CSF disorders, with special section for adults and kids. The course is aimed people who investigate and treat CSF disorders and includes...

Sight Sciences: Early Intervention with Implant-Free MIGS. The OMNI Surgical System

Agenda 18:30 Arrival & Refreshments19:00 Introductions & Welcome : Ms. Indira Madgula (Moderator), Royal Preston Hospital19:15 The Patients’ Perspective : Why MIGS, Why OMNI: Dr. Andrew Tatham, Princess Alexandra Eye Pavilion, Edinburgh19:45 Q&A - Discussion20:15 Close - Buffet Dinner

RCOphth Cornea Curriculum Course - 23 & 24 October 2025

The Royal College of Ophthalmologists Cornea Curriculum Course - 23 & 24 October 2025